These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38456232)

  • 21. Sedatives for opiate withdrawal in newborn infants.
    Osborn DA; Jeffery HE; Cole MJ
    Cochrane Database Syst Rev; 2002; (3):CD002053. PubMed ID: 12137641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treating Neonatal Abstinence Syndrome in a Rural Hospital: Lessons Learned.
    Gadomski A; Riley M; Ramiza K; Onofrey L; Zinkievich R; Krupa N; Scribani M
    Acad Pediatr; 2018; 18(4):425-429. PubMed ID: 29428413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey.
    Sarkar S; Donn SM
    J Perinatol; 2006 Jan; 26(1):15-7. PubMed ID: 16355103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gestational Age Alters Assessment of Neonatal Abstinence Syndrome.
    Amiri S; Nair J
    Pediatr Rep; 2022 Jan; 14(1):50-57. PubMed ID: 35225878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Escaping the Finnegan - Is it time?
    Singh R; Davis JM
    Semin Fetal Neonatal Med; 2021 Jun; 26(3):101218. PubMed ID: 33663940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Informing the Development of a Standardized Clinical Definition of Neonatal Abstinence Syndrome: Protocol for a Modified-Delphi Expert Panel.
    Khodyakov D; Jilani SM; Dellva S; Faherty LJ
    JMIR Res Protoc; 2021 Sep; 10(9):e25387. PubMed ID: 34491203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opiate treatment for opiate withdrawal in newborn infants.
    Osborn DA; Cole MJ; Jeffery HE
    Cochrane Database Syst Rev; 2002; (3):CD002059. PubMed ID: 12137642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-pharmacological care for opioid withdrawal in newborns.
    Pahl A; Young L; Buus-Frank ME; Marcellus L; Soll R
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013217. PubMed ID: 33348423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beyond the Finnegan scoring system: Novel assessment and diagnostic techniques for the opioid-exposed infant.
    Schiff DM; Grossman MR
    Semin Fetal Neonatal Med; 2019 Apr; 24(2):115-120. PubMed ID: 30738754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of hospital discharge coding for neonatal abstinence syndrome.
    Yam P; Lok L; Eastwood J; Maher C; Ward M; Clews S; Falconer J; Oei JL
    Acta Paediatr; 2019 Oct; 108(10):1786-1792. PubMed ID: 30924956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opiate treatment for opiate withdrawal in newborn infants.
    Osborn DA; Jeffery HE; Cole M
    Cochrane Database Syst Rev; 2005 Jul; (3):CD002059. PubMed ID: 16034871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neonatal opioid toxicity: opioid withdrawal (abstinence) syndrome with emphasis on pharmacogenomics and respiratory depression.
    Baldo BA
    Arch Toxicol; 2023 Oct; 97(10):2575-2585. PubMed ID: 37537419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Possibility of Early Discharge for Newborns Being Monitored for Neonatal Abstinence Syndrome Based on Modified Finnegan Score Distributions.
    Oji-Mmuo CN; Schaefer EW; Liao L; Kaiser JR; Sekhar DL
    Clin Pediatr (Phila); 2019 Jun; 58(6):641-646. PubMed ID: 30813757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eat, Sleep, Console Approach or Usual Care for Neonatal Opioid Withdrawal.
    Young LW; Ounpraseuth ST; Merhar SL; Hu Z; Simon AE; Bremer AA; Lee JY; Das A; Crawford MM; Greenberg RG; Smith PB; Poindexter BB; Higgins RD; Walsh MC; Rice W; Paul DA; Maxwell JR; Telang S; Fung CM; Wright T; Reynolds AM; Hahn DW; Ross J; McAllister JM; Crowley M; Shaikh SK; Puopolo KM; Christ L; Brown J; Riccio J; Wong Ramsey K; Akshatha ; Braswell EF; Tucker L; McAlmon KR; Dummula K; Weiner J; White JR; Howell MP; Newman S; Snowden JN; Devlin LA;
    N Engl J Med; 2023 Jun; 388(25):2326-2337. PubMed ID: 37125831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maternal opioid use disorder and neonatal abstinence syndrome in northwest Ontario: a 7-year retrospective analysis.
    Dooley J; Ryan G; Gerber Finn L; Bollinger M; Matsumoto CL; Hopman WM; Kelly L
    Can J Rural Med; 2018; 23(2):39-44. PubMed ID: 29547380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants.
    Levinson-Castiel R; Merlob P; Linder N; Sirota L; Klinger G
    Arch Pediatr Adolesc Med; 2006 Feb; 160(2):173-6. PubMed ID: 16461873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does Maternal Incarceration Impact Infants with Neonatal Abstinence Syndrome?
    Drago MJ; Shabanova V; Hochreiter D; Grossman M; Mercurio M
    Matern Child Health J; 2022 May; 26(5):1095-1103. PubMed ID: 35088297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A New Scoring System for the Assessment of Neonatal Abstinence Syndrome.
    Kocherlakota P; Qian EC; Patel VC; Mandru C; Vilar RE; Alpan G; La Gamma EF
    Am J Perinatol; 2020 Feb; 37(3):333-340. PubMed ID: 31777045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neonatal Abstinence Syndrome: Prevention, Recognition, Treatment, and Follow-up.
    Schroeder M; White J
    S D Med; 2021 Dec; 74(12):576-583. PubMed ID: 35015949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of pharmaceutical drugs of dependence to the incidence of neonatal abstinence syndrome in Western Australia between 2003 and 2018.
    Kelty EA; Cumming CN; Preen DB
    Pharmacotherapy; 2022 May; 42(5):405-410. PubMed ID: 35342965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.